Safety of Botulinum Toxin A in Children and Adolescents with Cerebral Palsy in a Pragmatic Setting

Safety of Botulinum Toxin A in Children and Adolescents with Cerebral Palsy in a Pragmatic Setting

This retrospective study aimed to examine the safety of botulinum toxin A (BoNT-A) treatment in a paediatric multidisciplinary cerebral palsy clinic. In a sample of 454 patients who had 1515 BoNT-A sessions, data on adverse events were available in 356 patients and 1382 sessions; 51 non-fatal advers...

Full description

Bibliographic Details
Main Authors: George Mitsou, Panagiotis Bouros, Katerina Foska, Irene Nikaina, Antigone S. Papavasiliou, Constantine Filiopoulos
Format: Article
Language:English
Published: MDPI AG 2013-03-01
Series:Toxins
Subjects:
cerebral palsy
spasticity
treatment
botulinum toxin A
onabotulinumtoxin A
abobotulinumtoxin A
adverse events
safety
Online Access:http://www.mdpi.com/2072-6651/5/3/524

Internet

http://www.mdpi.com/2072-6651/5/3/524

Similar Items